Showing results (131-140 of 149) with videos related to
Sort By:
Pageof 15
Alzheimer Disease and Associated Disorders|January 1, 1997
Validity and reliability of the Alzheimer's Disease Cooperative Study-Clinical Global Impression of Change. The Alzheimer's Disease Cooperative StudyL S Schneider, J T Olin, R S Doody, et al.The British Journal of Dermatology|September 1, 1999
Combination treatment with methotrexate and cyclosporin for severe recalcitrant psoriasisC M Clark, B Kirby, A D Morris, et al.Journal of General Internal Medicine|January 1, 1988
The Diabetes Education Study: a controlled trial of the effects of intensive instruction of internal medicine residents on the management of diabetes mellitusS A Mazzuca, F Vinicor, S J Cohen, et al.American Journal of Human Genetics|March 11, 1991
Linkage analysis of familial Alzheimer disease, using chromosome 21 markersG D Schellenberg, M A Pericak-Vance, E M Wijsman, et al.Neurology|May 24, 2000
Alpha-synuclein cortical Lewy bodies correlate with dementia in Parkinson's diseaseH I Hurtig, J Q Trojanowski, J Galvin, et al.Annals of Neurology|February 28, 2001
Loss of brain tau defines novel sporadic and familial tauopathies with frontotemporal dementiaV Zhukareva, V Vogelsberg-Ragaglia, V M Van Deerlin, et al.Experimental Neurology|December 1, 1988
Genetic linkage studies in Alzheimer's disease familiesM A Pericak-Vance, L H Yamaoka, C S Haynes, et al.Neurology|May 7, 2008
CSF biomarkers in frontotemporal lobar degeneration with known pathologyH Bian, J C Van Swieten, S Leight, et al.Neurology|August 10, 2005
Rate of progression differs in frontotemporal dementia and Alzheimer diseaseK Rascovsky, D P Salmon, A M Lipton, et al.Journal of Neurology, Neurosurgery, and Psychiatry|February 1, 1996
Comparison of positron emission tomography, cognition, and brain volume in Alzheimer's disease with and without severe abnormalities of white matterC DeCarli, C L Grady, C M Clark, et al.Pageof 15